Source: LAB PRODUCT NEWS

CLS: Novel approach treats C. difficile hospital infections

Calgary, AB - Using data collected at the Canadian Light Source, researchers have revealed the first molecular views showing how antibodies derived from llamas may provide a new method for controlling the highly infectious disease C. difficile,...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100